Chardan Healthcare Acquisition 2 Corp. (CHAQ) News
Filter CHAQ News Items
CHAQ News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
CHAQ News Highlights
- CHAQ's 30 day story count now stands at 2.
- Over the past 7 days, the trend for CHAQ's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about CHAQ are GENE and DE.
Latest CHAQ News From Around the Web
Below are the latest news stories about Chardan Healthcare Acquisition 2 Corp that investors may wish to consider to help them evaluate CHAQ as an investment opportunity.
Chardan Healthcare Acquisition 2 Corp. Announces Stockholder Approval Of Business Combination With Renovacor, Inc.Chardan Healthcare Acquisition 2 Corp. (NYSE: CHAQ) ("CHAQ"), a special purpose acquisition company sponsored by Chardan Capital Markets ("Chardan"), today announced the results for the proposals considered and voted upon by its stockholders at its special meeting held on September 1, 2021 (the "Special Meeting"), regarding the proposed business combination with Renovacor, Inc. ("Renovacor"), an early‑stage biotechnology company developing adeno-associated virus (AAV)‑based gene therapies for de |
Chardan Healthcare Acquisition 2 Corp. Announces Renovacor's Appointment of Matt Killeen, Ph.D., as Chief Scientific OfficerRenovacor, Inc. ("Renovacor"), an early–stage biotechnology company developing adeno-associated virus (AAV)–based gene therapies for devastating cardiovascular and central nervous system diseases resulting from BAG3 gene variants, today announced the appointment of Matt Killeen, Ph.D., as chief scientific officer (CSO), effective as of September 1, 2021. Chardan Healthcare Acquisition 2 Corp. (CHAQ) previously announced on March 23, 2021 that it entered into a definitive merger agreement with Re |
Chardan Healthcare Acquisition 2 Corp. Announces Record Date for Stockholders Eligible to Vote on MergerPHILADELPHIA and NEW YORK, Aug. 3, 2021 /PRNewswire/ -- Chardan Healthcare Acquisition 2 Corp. (the "Company") announced that the close of business on Thursday, August 5, 2021, has been set as the record date for the determination of stockholders eligible to receive the proxy and vote at |
Renovacor Announces the Appointment of Elizabeth White, Ph.D., as Chief Business Officer and Senior Vice President of OperationsDr. White is an industry leader with over three decades of pharmaceutical experience in business management and strategy with a focus on rare diseases and gene therapiesPHILADELPHIA, July 19, 2021 (GLOBE NEWSWIRE) -- Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing adeno-associated virus (AAV)‑based gene therapies for devastating cardiovascular and central nervous system diseases resulting from BAG3 gene variants, today announced the appointment of Elizabeth (Beth) |
Renovacor Announces the Appointment of Jiwen Zhang, Ph.D., as Senior Vice President, Regulatory Affairs and Quality AssuranceDr. Zhang has over 20 years of experience in regulatory affairs, with over a decade specifically in the field of cell and gene therapyPHILADELPHIA, July 12, 2021 (GLOBE NEWSWIRE) -- Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing adeno-associated virus (AAV)‑based gene therapies for devastating cardiovascular and central nervous system diseases resulting from BAG3 gene variants, today announced the appointment of Jiwen Zhang, Ph.D., as senior vice president, regula |
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigation of PACX, CHAQ, FMBI, and FST MergersWILMINGTON, Del., July 02, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating: Pioneer Merger Corp. (NASDAQ GS: PACX) regarding possible breaches of fiduciary duties and other violations of law related to Pioneer’s agreement to merge with Acorns Grow Incorporated. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-pioneer-merger-corp. Chardan Healthcare Acquisition 2 Corp. (NYSE: CHAQ) regarding possible breaches of fiduciar |
Renovacor Announces the Appointments of Joan Lau, Ph.D., and Gregory F. Covino to its Board of DirectorsAppointments to be effective upon closing of the previously announced merger between Renovacor and Chardan Healthcare Acquisition 2 Corp. Appointments to be effective upon closing of the previously announced merger between Renovacor and Chardan Healthcare Acquisition 2 Corp. |
Lifshitz Law Firm, P.C. Announces Investigation of ARPO, CNBKA, CHAQ, DSSI, INSW, FORE, FTIV, ONB, FMBI, and GRAAerpio Pharmaceuticals, Inc. (NasdaqCM: ARPO) |
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Chardan Healthcare Acquisition 2 Corp. MergerWILMINGTON, Del., June 07, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating Chardan Healthcare Acquisition 2 Corp. (Chardan Healthcare) (NYSE: CHAQ ) regarding possible breaches of fiduciary duties and other violations of law related to Chardan Healthcares agreement to merge with Renovacor, Inc. |
Renovacor Announces the Appointment of Marc Semigran, M.D., as Chief Medical OfficerFormer chief medical officer of MyoKardia to lead clinical development at RenovacorPHILADELPHIA and BOSTON, June 02, 2021 (GLOBE NEWSWIRE) -- Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing adeno-associated virus (AAV)‑based gene therapies for devastating cardiovascular and central nervous system (“CNS”) diseases resulting from BAG3 gene variants, today announced the appointment of Marc Semigran, M.D., as chief medical officer of Renovacor. Dr. Semigran brings cons |